BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, Hays AP, Lovelace RE, Butler I, Bertorini TE. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994;44:721-7. [PMID: 8164833 DOI: 10.1212/wnl.44.4.721] [Cited by in Crossref: 295] [Cited by in F6Publishing: 74] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Pacitti D, Levene M, Garone C, Nirmalananthan N, Bax BE. Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far. Front Genet 2018;9:669. [PMID: 30627136 DOI: 10.3389/fgene.2018.00669] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
2 Scaglia F, Scheuerle AE, Towbin JA, Armstrong DL, Sweetman L, Wong LJ. Neonatal presentation of ventricular tachycardia and a Reye-like syndrome episode associated with disturbed mitochondrial energy metabolism. BMC Pediatr 2002;2:12. [PMID: 12507404 DOI: 10.1186/1471-2431-2-12] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
3 Gropman AL. Diagnosis and treatment of childhood mitochondrial diseases. Curr Neurol Neurosci Rep. 2001;1:185-194. [PMID: 11898515 DOI: 10.1007/s11910-001-0015-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
4 Dhillon S, Hellings JA, Butler MG. Genetics and mitochondrial abnormalities in autism spectrum disorders: a review. Curr Genomics 2011;12:322-32. [PMID: 22294875 DOI: 10.2174/138920211796429745] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
5 Cho J, Seo J, Lim CH, Yang L, Shiratsuchi T, Lee MH, Chowdhury RR, Kasahara H, Kim JS, Oh SP, Lee YJ, Terada N. Mitochondrial ATP transporter Ant2 depletion impairs erythropoiesis and B lymphopoiesis. Cell Death Differ 2015;22:1437-50. [PMID: 25613378 DOI: 10.1038/cdd.2014.230] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
6 Valentino ML, Martí R, Tadesse S, López LC, Manes JL, Lyzak J, Hahn A, Carelli V, Hirano M. Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). FEBS Lett 2007;581:3410-4. [PMID: 17612528 DOI: 10.1016/j.febslet.2007.06.042] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
7 van der Knaap MS, Jakobs C, Valk J. Magnetic resonance imaging in lactic acidosis. J Inherit Metab Dis 1996;19:535-47. [PMID: 8884577 DOI: 10.1007/BF01799114] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
8 Karyampudi A, Srivastava P, Mandal K, Yadav P, Ghoshal UC, Verma A, Phadke SR. Novel sequence variations in the thymidine phosphorylase gene causing mitochondrial neurogastrointestinal encephalopathy. Clin Dysmorphol 2016;25:156-62. [PMID: 27261974 DOI: 10.1097/MCD.0000000000000137] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Higuchi M, Kudo T, Suzuki S, Evans TT, Sasaki R, Wada Y, Shirakawa T, Sawyer JR, Gotoh A. Mitochondrial DNA determines androgen dependence in prostate cancer cell lines. Oncogene 2006;25:1437-45. [PMID: 16278679 DOI: 10.1038/sj.onc.1209190] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 3.9] [Reference Citation Analysis]
10 Erdogan MA, Seckin Y, Harputluoglu MM, Karincaoglu M, Aladag M, Caliskan AR, Bilgic Y, Yildirim O, Cagin YF, Atayan Y, Cengiz AN, Emul C, Esener Z, Erbay MF, Tekedereli I. A mitochondrial neurogastrointestinal encephalomyopathy with intestinal pseudo-obstruction resulted from a novel splice site mutation. Clin Dysmorphol 2019;28:22-5. [PMID: 30407211 DOI: 10.1097/MCD.0000000000000250] [Reference Citation Analysis]
11 Bronckaers A, Gago F, Balzarini J, Liekens S. The dual role of thymidine phosphorylase in cancer development and chemotherapy. Med Res Rev. 2009;29:903-953. [PMID: 19434693 DOI: 10.1002/med.20159] [Cited by in Crossref: 128] [Cited by in F6Publishing: 120] [Article Influence: 10.7] [Reference Citation Analysis]
12 Bax BE. Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment. J Transl Genet Genom 2020;4:1-16. [PMID: 32914088 DOI: 10.20517/jtgg.2020.08] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Nishigaki Y, Martí R, Copeland WC, Hirano M. Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest 2003;111:1913-21. [PMID: 12813027 DOI: 10.1172/JCI17828] [Cited by in Crossref: 125] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
14 Levene M, Bain MD, Moran NF, Nirmalananthan N, Poulton J, Scarpelli M, Filosto M, Mandel H, MacKinnon AD, Fairbanks L, Pacitti D, Bax BE. Safety and Efficacy of Erythrocyte Encapsulated Thymidine Phosphorylase in Mitochondrial Neurogastrointestinal Encephalomyopathy. J Clin Med 2019;8:E457. [PMID: 30959750 DOI: 10.3390/jcm8040457] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
15 Bax BE, Levene M, Bain MD, Fairbanks LD, Filosto M, Kalkan Uçar S, Klopstock T, Kornblum C, Mandel H, Rahman S, Roubertie A, Scarpelli M, Sedgwick PM, Baru M, Sellos-Moura M, Price J, Horn P, Nirmalananthan N. Erythrocyte Encapsulated Thymidine Phosphorylase for the Treatment of Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy: Study Protocol for a Multi-Centre, Multiple Dose, Open Label Trial. J Clin Med 2019;8:E1096. [PMID: 31344955 DOI: 10.3390/jcm8081096] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
16 Antonucci A, Fronzoni L, Cogliandro L, Cogliandro RF, Caputo C, Giorgio RD, Pallotti F, Barbara G, Corinaldesi R, Stanghellini V. Chronic intestinal pseudo-obstruction. World J Gastroenterol 2008; 14(19): 2953-2961 [PMID: 18494042 DOI: 10.3748/wjg.14.2953] [Cited by in CrossRef: 129] [Cited by in F6Publishing: 91] [Article Influence: 9.2] [Reference Citation Analysis]
17 Gopan A, Sarma MS. Mitochondrial hepatopathy: Respiratory chain disorders- ‘breathing in and out of the liver’. World J Hepatol 2021; 13(11): 1707-1726 [PMID: 34904040 DOI: 10.4254/wjh.v13.i11.1707] [Reference Citation Analysis]
18 Yadak R, Cabrera-Pérez R, Torres-Torronteras J, Bugiani M, Haeck JC, Huston MW, Bogaerts E, Goffart S, Jacobs EH, Stok M, Leonardelli L, Biasco L, Verdijk RM, Bernsen MR, Ruijter G, Martí R, Wagemaker G, van Til NP, de Coo IFM. Preclinical Efficacy and Safety Evaluation of Hematopoietic Stem Cell Gene Therapy in a Mouse Model of MNGIE. Mol Ther Methods Clin Dev 2018;8:152-65. [PMID: 29687034 DOI: 10.1016/j.omtm.2018.01.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
19 Nogueira C, Almeida LS, Nesti C, Pezzini I, Videira A, Vilarinho L, Santorelli FM. Syndromes associated with mitochondrial DNA depletion. Ital J Pediatr 2014;40:34. [PMID: 24708634 DOI: 10.1186/1824-7288-40-34] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
20 Lock JH, Irani NK, Newman NJ. Neuro-ophthalmic manifestations of mitochondrial disorders and their management. Taiwan J Ophthalmol 2021;11:39-52. [PMID: 33767954 DOI: 10.4103/tjo.tjo_68_20] [Reference Citation Analysis]
21 Dimauro S. A history of mitochondrial diseases. J Inherit Metab Dis 2011;34:261-76. [PMID: 20490929 DOI: 10.1007/s10545-010-9082-x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
22 Di Leo R, Musumeci O, de Gregorio C, Recupero A, Grimaldi P, Messina C, Coglitore S, Vita G, Toscano A. Evidence of cardiovascular autonomic impairment in mitochondrial disorders. J Neurol 2007;254:1498-503. [PMID: 17987253 DOI: 10.1007/s00415-007-0536-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
23 Boschetti E, D'Angelo R, Tardio ML, Costa R, Giordano C, Accarino A, Malagelada C, Clavenzani P, Tugnoli V, Caio G, Righi V, Garone C, D'Errico A, Cenacchi G, Dotti MT, Stanghellini V, Sternini C, Pironi L, Rinaldi R, Carelli V, De Giorgio R. Evidence of enteric angiopathy and neuromuscular hypoxia in patients with mitochondrial neurogastrointestinal encephalomyopathy. Am J Physiol Gastrointest Liver Physiol 2021;320:G768-79. [PMID: 33655764 DOI: 10.1152/ajpgi.00047.2021] [Reference Citation Analysis]
24 Yadak R, Sillevis Smitt P, van Gisbergen MW, van Til NP, de Coo IF. Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options. Front Cell Neurosci 2017;11:31. [PMID: 28261062 DOI: 10.3389/fncel.2017.00031] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
25 Yadak R, Breur M, Bugiani M. Gastrointestinal Dysmotility in MNGIE: from thymidine phosphorylase enzyme deficiency to altered interstitial cells of Cajal. Orphanet J Rare Dis. 2019;14:33. [PMID: 30736844 DOI: 10.1186/s13023-019-1016-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
26 Finsterer J, Frank M. Gastrointestinal manifestations of mitochondrial disorders: a systematic review. Therap Adv Gastroenterol. 2017;10:142-154. [PMID: 28286566 DOI: 10.1177/1756283x16666806] [Cited by in Crossref: 40] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
27 Sedel F, Tourbah A, Fontaine B, Lubetzki C, Baumann N, Saudubray JM, Lyon-Caen O. Leukoencephalopathies associated with inborn errors of metabolism in adults. J Inherit Metab Dis 2008;31:295-307. [PMID: 18344012 DOI: 10.1007/s10545-008-0778-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
28 Levene M, Pacitti D, Gasson C, Hall J, Sellos-Moura M, Bax BE. Validation of an Immunoassay for Anti-thymidine Phosphorylase Antibodies in Patients with MNGIE Treated with Enzyme Replacement Therapy. Mol Ther Methods Clin Dev 2018;11:1-8. [PMID: 30294618 DOI: 10.1016/j.omtm.2018.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Masciullo M, Modoni A, Fattori F, Santoro M, Denora PS, Tonali P, Santorelli FM, Silvestri G. A novel mutation in the SACS gene associated with a complicated form of spastic ataxia. J Neurol 2008;255:1429-31. [PMID: 18604465 DOI: 10.1007/s00415-008-0936-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
30 Scarpelli M, Ricciardi GK, Beltramello A, Zocca I, Calabria F, Russignan A, Zappini F, Cotelli MS, Padovani A, Tomelleri G, Filosto M, Tonin P. The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy. Neuroradiol J 2013;26:520-30. [PMID: 24199812 DOI: 10.1177/197140091302600505] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
31 Torres-Torronteras J, Cabrera-Pérez R, Barba I, Costa C, de Luna N, Andreu AL, Barquinero J, Hirano M, Cámara Y, Martí R. Long-Term Restoration of Thymidine Phosphorylase Function and Nucleoside Homeostasis Using Hematopoietic Gene Therapy in a Murine Model of Mitochondrial Neurogastrointestinal Encephalomyopathy. Hum Gene Ther 2016;27:656-67. [PMID: 27004974 DOI: 10.1089/hum.2015.160] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
32 Hirano M, Garone C, Quinzii CM. CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders. Biochim Biophys Acta 2012;1820:625-31. [PMID: 22274133 DOI: 10.1016/j.bbagen.2012.01.006] [Cited by in Crossref: 66] [Cited by in F6Publishing: 54] [Article Influence: 6.6] [Reference Citation Analysis]
33 Halter JP, Michael W, Schüpbach M, Mandel H, Casali C, Orchard K, Collin M, Valcarcel D, Rovelli A, Filosto M, Dotti MT, Marotta G, Pintos G, Barba P, Accarino A, Ferra C, Illa I, Beguin Y, Bakker JA, Boelens JJ, de Coo IF, Fay K, Sue CM, Nachbaur D, Zoller H, Sobreira C, Pinto Simoes B, Hammans SR, Savage D, Martí R, Chinnery PF, Elhasid R, Gratwohl A, Hirano M. Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Brain 2015;138:2847-58. [PMID: 26264513 DOI: 10.1093/brain/awv226] [Cited by in Crossref: 88] [Cited by in F6Publishing: 72] [Article Influence: 12.6] [Reference Citation Analysis]
34 Mencias M, Levene M, Blighe K, Bax BE, On Behalf Of The Project Group. Circulating miRNAs as Biomarkers for Mitochondrial Neuro-Gastrointestinal Encephalomyopathy. Int J Mol Sci 2021;22:3681. [PMID: 33916195 DOI: 10.3390/ijms22073681] [Reference Citation Analysis]
35 Zeviani M, Petruzzella V, Carrozzo R. Disorders of nuclear-mitochondrial intergenomic signalling. J Bioenerg Biomembr 1997;29:121-30. [PMID: 9239538 DOI: 10.1023/a:1022633912917] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
36 Garcia-Diaz B, Garone C, Barca E, Mojahed H, Gutierrez P, Pizzorno G, Tanji K, Arias-Mendoza F, Quinzii CM, Hirano M. Deoxynucleoside stress exacerbates the phenotype of a mouse model of mitochondrial neurogastrointestinal encephalopathy. Brain 2014;137:1337-49. [PMID: 24727567 DOI: 10.1093/brain/awu068] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
37 Viscomi C, Zeviani M. MtDNA-maintenance defects: syndromes and genes. J Inherit Metab Dis 2017;40:587-99. [PMID: 28324239 DOI: 10.1007/s10545-017-0027-5] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 16.8] [Reference Citation Analysis]
38 Boschetti E, D'Alessandro R, Bianco F, Carelli V, Cenacchi G, Pinna AD, Del Gaudio M, Rinaldi R, Stanghellini V, Pironi L, Rhoden K, Tugnoli V, Casali C, De Giorgio R. Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy. PLoS One 2014;9:e96692. [PMID: 24802030 DOI: 10.1371/journal.pone.0096692] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
39 López LC, Akman HO, García-Cazorla A, Dorado B, Martí R, Nishino I, Tadesse S, Pizzorno G, Shungu D, Bonilla E, Tanji K, Hirano M. Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice. Hum Mol Genet 2009;18:714-22. [PMID: 19028666 DOI: 10.1093/hmg/ddn401] [Cited by in Crossref: 97] [Cited by in F6Publishing: 93] [Article Influence: 6.9] [Reference Citation Analysis]
40 Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr 1997;29:131-49. [PMID: 9239539 DOI: 10.1023/a:1022685929755] [Cited by in Crossref: 307] [Cited by in F6Publishing: 73] [Article Influence: 12.3] [Reference Citation Analysis]
41 Casarez VQ, Zavala AM, Owusu-Agyemang P, Hagan K. Anesthetic Management of a Child with Mitochondrial Neurogastrointestinal Encephalopathy. Case Rep Anesthesiol 2015;2015:453714. [PMID: 26124966 DOI: 10.1155/2015/453714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, Anselm I, Cohen BH, Falk MJ, Greene C, Gropman AL, Haas R, Hirano M, Morgan P, Sims K, Tarnopolsky M, Van Hove JL, Wolfe L, DiMauro S. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med 2015;17:689-701. [PMID: 25503498 DOI: 10.1038/gim.2014.177] [Cited by in Crossref: 226] [Cited by in F6Publishing: 169] [Article Influence: 28.3] [Reference Citation Analysis]
43 Haraguchi M, Tsujimoto H, Fukushima M, Higuchi I, Kuribayashi H, Utsumi H, Nakayama A, Hashizume Y, Hirato J, Yoshida H, Hara H, Hamano S, Kawaguchi H, Furukawa T, Miyazono K, Ishikawa F, Toyoshima H, Kaname T, Komatsu M, Chen ZS, Gotanda T, Tachiwada T, Sumizawa T, Miyadera K, Osame M, Yoshida H, Noda T, Yamada Y, Akiyama S. Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice. Mol Cell Biol 2002;22:5212-21. [PMID: 12077348 DOI: 10.1128/MCB.22.14.5212-5221.2002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
44 Ronchi D, Caporali L, Manenti GF, Meneri M, Mohamed S, Bordoni A, Tagliavini F, Contin M, Piga D, Sciacco M, Saetti C, Carelli V, Comi GP. TYMP Variants Result in Late-Onset Mitochondrial Myopathy With Altered Muscle Mitochondrial DNA Homeostasis. Front Genet 2020;11:860. [PMID: 32849836 DOI: 10.3389/fgene.2020.00860] [Reference Citation Analysis]
45 Pavlakis SG, Hirano M. Mitochondrial Diseases: A Clinical and Molecular History. Pediatr Neurol 2016;63:3-5. [PMID: 27460527 DOI: 10.1016/j.pediatrneurol.2016.05.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Van Goethem G, Martin JJ, Van Broeckhoven C. Progressive external ophthalmoplegia characterized by multiple deletions of mitochondrial DNA: unraveling the pathogenesis of human mitochondrial DNA instability and the initiation of a genetic classification. Neuromolecular Med 2003;3:129-46. [PMID: 12835509 DOI: 10.1385/NMM:3:3:129] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
47 Sicurelli F, Carluccio MA, Toraldo F, Tozzi M, Bucalossi A, Lenoci M, Jacomelli G, Micheli V, Cardaioli E, Mondelli M, Federico A, Marotta G, Dotti MT. Clinical and biochemical improvement following HSCT in a patient with MNGIE: 1-year follow-up. J Neurol 2012;259:1985-7. [PMID: 22532170 DOI: 10.1007/s00415-012-6500-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
48 Puusepp S, Kovacs-Nagy R, Alhaddad B, Braunisch M, Hoffmann GF, Kotzaeridou U, Lichvarova L, Liiv M, Makowski C, Mandel M, Meitinger T, Pajusalu S, Rodenburg RJ, Safiulina D, Strom TM, Talvik I, Vaarmann A, Wilson C, Kaasik A, Haack TB, Õunap K. Compound heterozygous SPATA5 variants in four families and functional studies of SPATA5 deficiency. Eur J Hum Genet 2018;26:407-19. [PMID: 29343804 DOI: 10.1038/s41431-017-0001-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
49 Röeben B, Marquetand J, Bender B, Billing H, Haack TB, Sanchez-Albisua I, Schöls L, Blom HJ, Synofzik M. Hemodialysis in MNGIE transiently reduces serum and urine levels of thymidine and deoxyuridine, but not CSF levels and neurological function. Orphanet J Rare Dis 2017;12:135. [PMID: 28764801 DOI: 10.1186/s13023-017-0687-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
50 Ormeci AC, Akyuz F, Baran B, Gokturk S, Ormeci T, Pinarbasi B, Mutluay Soyer O, Evirgen S, Akyuz U, Karaca C, Demir K, Kaymakoglu S, Besisik F. Retention during capsule endoscopy: Is it a real problem in routine practice? J Int Med Res 2016;44:968-75. [PMID: 27377071 DOI: 10.1177/0300060516645420] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
51 Granero Castro P, Fernández Arias S, Moreno Gijón M, Alvarez Martínez P, Granero Trancón J, Álvarez Pérez JA, Lamamie Clairac E, González González JJ. Emergency surgery in chronic intestinal pseudo-obstruction due to mitochondrial neurogastrointestinal encephalomyopathy: case reports. Int Arch Med. 2010;3:35. [PMID: 21143863 DOI: 10.1186/1755-7682-3-35] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
52 Lee S, Na JH, Lee YM. Epilepsy in Leigh Syndrome With Mitochondrial DNA Mutations. Front Neurol 2019;10:496. [PMID: 31139141 DOI: 10.3389/fneur.2019.00496] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
53 El-Hattab AW, Scaglia F. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics 2013;10:186-98. [PMID: 23385875 DOI: 10.1007/s13311-013-0177-6] [Cited by in Crossref: 163] [Cited by in F6Publishing: 142] [Article Influence: 18.1] [Reference Citation Analysis]
54 Zimmer V, Feiden W, Becker G, Zimmer A, Reith W, Raedle J, Lammert F, Zeuzem S, Hirano M, Menges M. Absence of the interstitial cell of Cajal network in mitochondrial neurogastrointestinal encephalomyopathy. Neurogastroenterol Motil 2009;21:627-31. [PMID: 19368660 DOI: 10.1111/j.1365-2982.2009.01264.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
55 Di Meo I, Lamperti C, Tiranti V. Mitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approaches. EMBO Mol Med. 2015;7:1257-1266. [PMID: 26194912 DOI: 10.15252/emmm.201505040] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
56 Cardaioli E, Da Pozzo P, Malfatti E, Battisti C, Gallus GN, Gaudiano C, Macucci M, Malandrini A, Margollicci M, Rubegni A, Dotti MT, Federico A. A second MNGIE patient without typical mitochondrial skeletal muscle involvement. Neurol Sci 2010;31:491-4. [PMID: 20232099 DOI: 10.1007/s10072-010-0225-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
57 Tan EY, Boelens JJ, Jones SA, Wynn RF. Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism. Front Pediatr 2019;7:433. [PMID: 31709204 DOI: 10.3389/fped.2019.00433] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
58 Parsons T, Weimer L, Engelstad K, Linker A, Battista V, Wei Y, Hirano M, Dimauro S, De Vivo DC, Kaufmann P. Autonomic symptoms in carriers of the m.3243A& gt; G mitochondrial DNA mutation. Arch Neurol. 2010;67:976-979. [PMID: 20697048 DOI: 10.1001/archneurol.2010.174] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
59 DiMauro S. Introduction: mitochondrial encephalomyopathies. Brain Pathol 2000;10:419-21. [PMID: 10885660 [PMID: 10885660 DOI: 10.1111/j.1750-3639.2000.tb00273.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
60 Zimmer V, Zimmer A, Hirano M, Lammert F. Recalcitrant vomiting, disturbed eye movements, and leukoencephalopathy. Mitochondrial neurogastrointestinal encephalomyopathy. Gastroenterology 2009;137:1581, 1861. [PMID: 19789089 DOI: 10.1053/j.gastro.2009.06.056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
61 Stumpf JD, Saneto RP, Copeland WC. Clinical and molecular features of POLG-related mitochondrial disease. Cold Spring Harb Perspect Biol 2013;5:a011395. [PMID: 23545419 DOI: 10.1101/cshperspect.a011395] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 9.0] [Reference Citation Analysis]
62 Wanrooij S, Luoma P, van Goethem G, van Broeckhoven C, Suomalainen A, Spelbrink JN. Twinkle and POLG defects enhance age-dependent accumulation of mutations in the control region of mtDNA. Nucleic Acids Res 2004;32:3053-64. [PMID: 15181170 DOI: 10.1093/nar/gkh634] [Cited by in Crossref: 92] [Cited by in F6Publishing: 88] [Article Influence: 5.1] [Reference Citation Analysis]
63 Tang S, Dimberg EL, Milone M, Wong LJ. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations. J Neurol. 2012;259:862-868. [PMID: 21993618 DOI: 10.1007/s00415-011-6268-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
64 Duran J, Martinez A, Adler E. Cardiovascular Manifestations of Mitochondrial Disease. Biology (Basel) 2019;8:E34. [PMID: 31083569 DOI: 10.3390/biology8020034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
65 Yadak R, Boot MV, van Til NP, Cazals-Hatem D, Finkenstedt A, Bogaerts E, de Coo IF, Bugiani M. Transplantation, gene therapy and intestinal pathology in MNGIE patients and mice. BMC Gastroenterol 2018;18:149. [PMID: 30340467 DOI: 10.1186/s12876-018-0881-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
66 Torres-Torronteras J, Cabrera-Pérez R, Vila-Julià F, Viscomi C, Cámara Y, Hirano M, Zeviani M, Martí R. Long-Term Sustained Effect of Liver-Targeted Adeno-Associated Virus Gene Therapy for Mitochondrial Neurogastrointestinal Encephalomyopathy. Hum Gene Ther 2018;29:708-18. [PMID: 29284302 DOI: 10.1089/hum.2017.133] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
67 Garone C, Tadesse S, Hirano M. Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. Brain. 2011;134:3326-3332. [PMID: 21933806 DOI: 10.1093/brain/awr245] [Cited by in Crossref: 127] [Cited by in F6Publishing: 111] [Article Influence: 11.5] [Reference Citation Analysis]
68 Zimmer V, Hirano M, Zimmer A, Lammert F. Diagnosis of mitochondrial neurogastrointestinal encephalomyopathy: proposal of a clinical algorithm. Dig Liver Dis 2014;46:664-5. [PMID: 24726585 DOI: 10.1016/j.dld.2014.03.006] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
69 Schon EA, DiMauro S, Hirano M, Gilkerson RW. Therapeutic prospects for mitochondrial disease. Trends Mol Med 2010;16:268-76. [PMID: 20556877 DOI: 10.1016/j.molmed.2010.04.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 6.3] [Reference Citation Analysis]
70 Hirano M, Vu TH. Defects of intergenomic communication: where do we stand? Brain Pathol 2000;10:451-61. [PMID: 10885664 DOI: 10.1111/j.1750-3639.2000.tb00277.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
71 Abdelnoor RV, Yule R, Elo A, Christensen AC, Meyer-Gauen G, Mackenzie SA. Substoichiometric shifting in the plant mitochondrial genome is influenced by a gene homologous to MutS. Proc Natl Acad Sci U S A 2003;100:5968-73. [PMID: 12730382 DOI: 10.1073/pnas.1037651100] [Cited by in Crossref: 171] [Cited by in F6Publishing: 140] [Article Influence: 9.0] [Reference Citation Analysis]
72 Poole OV, Uchiyama T, Skorupinska I, Skorupinska M, Germain L, Kozyra D, Holmes S, James N, Bugiardini E, Woodward C, Quinlivan R, Emmanuel A, Hanna MG, Panicker JN, Pitceathly RDS. Urogenital symptoms in mitochondrial disease: overlooked and undertreated. Eur J Neurol 2019;26:1111-20. [PMID: 30884027 DOI: 10.1111/ene.13952] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
73 Ng YS, Feeney C, Schaefer AM, Holmes CE, Hynd P, Alston CL, Grady JP, Roberts M, Maguire M, Bright A, Taylor RW, Yiannakou Y, McFarland R, Turnbull DM, Gorman GS. Pseudo-obstruction, stroke, and mitochondrial dysfunction: A lethal combination. Ann Neurol 2016;80:686-92. [PMID: 27453452 DOI: 10.1002/ana.24736] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
74 Hirano M, Garcia-de-Yebenes J, Jones AC, Nishino I, DiMauro S, Carlo JR, Bender AN, Hahn AF, Salberg LM, Weeks DE, Nygaard TG. Mitochondrial neurogastrointestinal encephalomyopathy syndrome maps to chromosome 22q13.32-qter. Am J Hum Genet 1998;63:526-33. [PMID: 9683610 DOI: 10.1086/301979] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 2.6] [Reference Citation Analysis]
75 D'Angelo R, Rinaldi R, Carelli V, Boschetti E, Caporali L, Capristo M, Casali C, Cenacchi G, Gramegna LL, Lodi R, Pinna AD, Pironi L, Stanzani M, Tonon C, D'Alessandro R, De Giorgio R. ITA-MNGIE: an Italian regional and national survey for mitochondrial neuro-gastro-intestinal encephalomyopathy. Neurol Sci 2016;37:1149-51. [PMID: 27007276 DOI: 10.1007/s10072-016-2552-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
76 Hirano M, Martí R, Casali C, Tadesse S, Uldrick T, Fine B, Escolar DM, Valentino ML, Nishino I, Hesdorffer C, Schwartz J, Hawks RG, Martone DL, Cairo MS, DiMauro S, Stanzani M, Garvin JH Jr, Savage DG. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 2006;67:1458-60. [PMID: 16971696 DOI: 10.1212/01.wnl.0000240853.97716.24] [Cited by in Crossref: 123] [Cited by in F6Publishing: 109] [Article Influence: 7.7] [Reference Citation Analysis]
77 Hendriksz CJ. Inborn errors of metabolism for the diagnostic radiologist. Pediatr Radiol 2009;39:211-20. [PMID: 19082997 DOI: 10.1007/s00247-008-1072-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]